Histologic, molecular, and cytogenetic features of ovarian cancers: Implications for diagnosis and treatment

Neeraj Lalwani, Srinivasa R. Prasad, Raghunandan Vikram, Alampady K. Shanbhogue, Phyllis C. Huettner, Najla Fasih

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Ovarian epithelial carcinoma (OEC), the most common ovarian malignancy, is a heterogeneous disease with several histologic subtypes that show characteristic cytogenetic features, molecular signatures, oncologic signaling pathways, and clinical-biologic behavior. Recent advances in histopathology and cytogenetics have provided insights into pathophysiologic features and natural history of OECs. Several studies have shown that high- or low-grade serous, endometrioid, and clear cell carcinomas are characterized by mutations involving the TP53, K-ras/BRAF, CTNNB1, and PIK3CA genes, respectively. High-grade serous carcinomas, the most common subtype, often manifest with early transcoelomic spread of disease beyond the ovaries, whereas lowgrade serous and mucinous carcinomas commonly manifest with early-stage disease, with a resultant excellent prognosis. On the basis of pathogenetic mechanisms, recent findings suggest a dualistic model of ovarian carcinogenesis consisting of types I and II. Type I (low-grade serous, mucinous, and endometrioid) cancers commonly arise from well-described, genetically stable precursor lesions (usually borderline tumors); manifest as large adnexal masses with early-stage disease; and have a relatively indolent clinical course, with an overall good prognosis. In contrast, type II carcinomas (high-grade serous, endometrioid, mixed, and undifferentiated variants) originate de novo from the adnexal epithelia, often demonstrate chromosomal instability, and have aggressive biologic behavior. Better knowledge of hereditary ovarian cancer syndromes and associated cytogenetic abnormalities has led to increased interest in novel biomarkers and molecular therapeutics. Genetic changes, pathologic features, imaging findings, and natural histories of a variety of histologic subtypes of OEC are discussed in this article.

Original languageEnglish (US)
Pages (from-to)625-646
Number of pages22
JournalRadiographics
Volume31
Issue number3
DOIs
StatePublished - May 2011

Fingerprint

Cytogenetics
Ovarian Neoplasms
Carcinoma
Natural History
Hereditary Neoplastic Syndromes
Mucinous Adenocarcinoma
Neoplasms
Chromosomal Instability
Critical Pathways
Biological Products
Chromosome Aberrations
Ovary
Carcinogenesis
Epithelium
Biomarkers
Mutation
Genes
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Lalwani, N., Prasad, S. R., Vikram, R., Shanbhogue, A. K., Huettner, P. C., & Fasih, N. (2011). Histologic, molecular, and cytogenetic features of ovarian cancers: Implications for diagnosis and treatment. Radiographics, 31(3), 625-646. https://doi.org/10.1148/rg.313105066

Histologic, molecular, and cytogenetic features of ovarian cancers : Implications for diagnosis and treatment. / Lalwani, Neeraj; Prasad, Srinivasa R.; Vikram, Raghunandan; Shanbhogue, Alampady K.; Huettner, Phyllis C.; Fasih, Najla.

In: Radiographics, Vol. 31, No. 3, 05.2011, p. 625-646.

Research output: Contribution to journalArticle

Lalwani, N, Prasad, SR, Vikram, R, Shanbhogue, AK, Huettner, PC & Fasih, N 2011, 'Histologic, molecular, and cytogenetic features of ovarian cancers: Implications for diagnosis and treatment', Radiographics, vol. 31, no. 3, pp. 625-646. https://doi.org/10.1148/rg.313105066
Lalwani, Neeraj ; Prasad, Srinivasa R. ; Vikram, Raghunandan ; Shanbhogue, Alampady K. ; Huettner, Phyllis C. ; Fasih, Najla. / Histologic, molecular, and cytogenetic features of ovarian cancers : Implications for diagnosis and treatment. In: Radiographics. 2011 ; Vol. 31, No. 3. pp. 625-646.
@article{7b36e31c99134acf87b17fa1aac8197a,
title = "Histologic, molecular, and cytogenetic features of ovarian cancers: Implications for diagnosis and treatment",
abstract = "Ovarian epithelial carcinoma (OEC), the most common ovarian malignancy, is a heterogeneous disease with several histologic subtypes that show characteristic cytogenetic features, molecular signatures, oncologic signaling pathways, and clinical-biologic behavior. Recent advances in histopathology and cytogenetics have provided insights into pathophysiologic features and natural history of OECs. Several studies have shown that high- or low-grade serous, endometrioid, and clear cell carcinomas are characterized by mutations involving the TP53, K-ras/BRAF, CTNNB1, and PIK3CA genes, respectively. High-grade serous carcinomas, the most common subtype, often manifest with early transcoelomic spread of disease beyond the ovaries, whereas lowgrade serous and mucinous carcinomas commonly manifest with early-stage disease, with a resultant excellent prognosis. On the basis of pathogenetic mechanisms, recent findings suggest a dualistic model of ovarian carcinogenesis consisting of types I and II. Type I (low-grade serous, mucinous, and endometrioid) cancers commonly arise from well-described, genetically stable precursor lesions (usually borderline tumors); manifest as large adnexal masses with early-stage disease; and have a relatively indolent clinical course, with an overall good prognosis. In contrast, type II carcinomas (high-grade serous, endometrioid, mixed, and undifferentiated variants) originate de novo from the adnexal epithelia, often demonstrate chromosomal instability, and have aggressive biologic behavior. Better knowledge of hereditary ovarian cancer syndromes and associated cytogenetic abnormalities has led to increased interest in novel biomarkers and molecular therapeutics. Genetic changes, pathologic features, imaging findings, and natural histories of a variety of histologic subtypes of OEC are discussed in this article.",
author = "Neeraj Lalwani and Prasad, {Srinivasa R.} and Raghunandan Vikram and Shanbhogue, {Alampady K.} and Huettner, {Phyllis C.} and Najla Fasih",
year = "2011",
month = "5",
doi = "10.1148/rg.313105066",
language = "English (US)",
volume = "31",
pages = "625--646",
journal = "Radiographics",
issn = "0271-5333",
publisher = "Radiological Society of North America Inc.",
number = "3",

}

TY - JOUR

T1 - Histologic, molecular, and cytogenetic features of ovarian cancers

T2 - Implications for diagnosis and treatment

AU - Lalwani, Neeraj

AU - Prasad, Srinivasa R.

AU - Vikram, Raghunandan

AU - Shanbhogue, Alampady K.

AU - Huettner, Phyllis C.

AU - Fasih, Najla

PY - 2011/5

Y1 - 2011/5

N2 - Ovarian epithelial carcinoma (OEC), the most common ovarian malignancy, is a heterogeneous disease with several histologic subtypes that show characteristic cytogenetic features, molecular signatures, oncologic signaling pathways, and clinical-biologic behavior. Recent advances in histopathology and cytogenetics have provided insights into pathophysiologic features and natural history of OECs. Several studies have shown that high- or low-grade serous, endometrioid, and clear cell carcinomas are characterized by mutations involving the TP53, K-ras/BRAF, CTNNB1, and PIK3CA genes, respectively. High-grade serous carcinomas, the most common subtype, often manifest with early transcoelomic spread of disease beyond the ovaries, whereas lowgrade serous and mucinous carcinomas commonly manifest with early-stage disease, with a resultant excellent prognosis. On the basis of pathogenetic mechanisms, recent findings suggest a dualistic model of ovarian carcinogenesis consisting of types I and II. Type I (low-grade serous, mucinous, and endometrioid) cancers commonly arise from well-described, genetically stable precursor lesions (usually borderline tumors); manifest as large adnexal masses with early-stage disease; and have a relatively indolent clinical course, with an overall good prognosis. In contrast, type II carcinomas (high-grade serous, endometrioid, mixed, and undifferentiated variants) originate de novo from the adnexal epithelia, often demonstrate chromosomal instability, and have aggressive biologic behavior. Better knowledge of hereditary ovarian cancer syndromes and associated cytogenetic abnormalities has led to increased interest in novel biomarkers and molecular therapeutics. Genetic changes, pathologic features, imaging findings, and natural histories of a variety of histologic subtypes of OEC are discussed in this article.

AB - Ovarian epithelial carcinoma (OEC), the most common ovarian malignancy, is a heterogeneous disease with several histologic subtypes that show characteristic cytogenetic features, molecular signatures, oncologic signaling pathways, and clinical-biologic behavior. Recent advances in histopathology and cytogenetics have provided insights into pathophysiologic features and natural history of OECs. Several studies have shown that high- or low-grade serous, endometrioid, and clear cell carcinomas are characterized by mutations involving the TP53, K-ras/BRAF, CTNNB1, and PIK3CA genes, respectively. High-grade serous carcinomas, the most common subtype, often manifest with early transcoelomic spread of disease beyond the ovaries, whereas lowgrade serous and mucinous carcinomas commonly manifest with early-stage disease, with a resultant excellent prognosis. On the basis of pathogenetic mechanisms, recent findings suggest a dualistic model of ovarian carcinogenesis consisting of types I and II. Type I (low-grade serous, mucinous, and endometrioid) cancers commonly arise from well-described, genetically stable precursor lesions (usually borderline tumors); manifest as large adnexal masses with early-stage disease; and have a relatively indolent clinical course, with an overall good prognosis. In contrast, type II carcinomas (high-grade serous, endometrioid, mixed, and undifferentiated variants) originate de novo from the adnexal epithelia, often demonstrate chromosomal instability, and have aggressive biologic behavior. Better knowledge of hereditary ovarian cancer syndromes and associated cytogenetic abnormalities has led to increased interest in novel biomarkers and molecular therapeutics. Genetic changes, pathologic features, imaging findings, and natural histories of a variety of histologic subtypes of OEC are discussed in this article.

UR - http://www.scopus.com/inward/record.url?scp=79958074821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958074821&partnerID=8YFLogxK

U2 - 10.1148/rg.313105066

DO - 10.1148/rg.313105066

M3 - Article

C2 - 21571648

AN - SCOPUS:79958074821

VL - 31

SP - 625

EP - 646

JO - Radiographics

JF - Radiographics

SN - 0271-5333

IS - 3

ER -